Wei-Chou Lin
Overview
Explore the profile of Wei-Chou Lin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
111
Citations
1419
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lee K, Pan S, Huang T, Lin W, Chiang Y
Taiwan J Obstet Gynecol
. 2024 Oct;
63(6):944-947.
PMID: 39482010
Objective: We presented a rare case of drug-induced thrombotic microangiopathy (DI-TMA) following chemotherapy with the regimen of bleomycin, etoposide, and cisplatin (BEP) in a patient with malignant ovarian germ cell...
2.
Tai Y, Lin W, Ye J, Chen D, Chen K, Wang D, et al.
Mod Pathol
. 2024 Oct;
38(1):100630.
PMID: 39395637
Ovarian clear cell carcinoma (OCCC) has a high incidence in Asia, with a frequent occurrence at an early stage, but without sufficient data on molecular stratification for high-risk patients. Recently,...
3.
Lin W, Wen M, Hsu Y, Kuo C, Chen T
Clin Transplant
. 2024 May;
38(6):e15335.
PMID: 38804610
Background: Antibody-mediated rejection (AMR) often leads to chronic kidney allograft damage and is a critical cause of allograft failure. The Banff classification, used to diagnose AMR, has become complex and...
4.
Liang P, Lin W, Wen M, Huang S, Fang P, Chuang H, et al.
Sci Rep
. 2023 Aug;
13(1):13260.
PMID: 37582967
Interstitial fibrosis assessment by renal pathologists lacks good agreement, and we aimed to investigate its hidden properties and infer possible clinical impact. Fifty kidney biopsies were assessed by 9 renal...
5.
Lin W, Chiu Y, Kuo K, Chow P, Hsu C, Liao S, et al.
Am J Cancer Res
. 2023 Aug;
13(7):3055-3066.
PMID: 37559983
Chondrosarcoma, a treatment-resistant cancer with limited therapeutic options, lacks significant advancements in treatment methods. However, PR-619, a novel inhibitor of deubiquitinating enzymes, has demonstrated anti-tumor effects in various malignancies. This...
6.
Su C, See D, Huang Y, Jao T, Liu S, Chou C, et al.
Circ Res
. 2023 May;
133(1):71-85.
PMID: 37232163
Background: As a part of natural disease progression, acute kidney injury (AKI) can develop into chronic kidney disease via renal fibrosis and inflammation. LTBP4 (latent transforming growth factor beta binding...
7.
Chuang G, Lin W, Chang L, Tsai I, Tsau Y
J Formos Med Assoc
. 2023 May;
122(11):1125-1131.
PMID: 37147241
Background: Cases of glomerulopathy after COVID-19 vaccination have been reported in the adult population, while only a few cases have been reported in children and adolescents. For better understanding of...
8.
Huang S, Lin Y, Wen M, Lin W, Fang P, Liang P, et al.
Sci Rep
. 2023 May;
13(1):7095.
PMID: 37127772
Interstitial inflammation scoring is incorporated into the Banff Classification of Renal Allograft Pathology and is essential for the diagnosis of T-cell mediated rejection. However, its reproducibility, including inter-rater and intra-rater...
9.
Wang W, Su C, Lin W, Huang C, Liu K
Kidney Int
. 2023 Feb;
103(3):642.
PMID: 36822758
No abstract available.
10.
Tsai Y, Wang T, Hsu C, Lin W, Chen J, Li J, et al.
Br J Cancer
. 2023 Feb;
128(9):1753-1764.
PMID: 36810912
Background: Although trimodality therapy resecting tumours followed by chemoradiotherapy is emerged for muscle-invasive bladder cancer (MIBC), chemotherapy produces toxicities. Histone deacetylase inhibitors have been identified as an effective strategy to...